Sun BioPharma proposes $11.5M follow-on

On Dec. 18, cancer company Sun BioPharma Inc. (OTCQB:SNBPD) proposed to raise $11.5 million through the sale of 834,000 units in a follow-on underwritten by Aegis Capital and Lake Street Capital Marke...